HDAC-IN-45(Compound 14)是一种具有抗癌活性且可与 Y303 残基形成氢键的小分子 HDAC 抑制剂,对 HDAC1、2 和 3 亚型具有显著抑制作用,IC50 分别为 0.108、0.585 和 0.563 μM。
产品编号: MS-K33205 CAS No.: 2421122-61-2 分子式: C25H20ClFN8O 分子量: 502.93
MolStrong 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务
规格 价格 是否有货 数量 购物车
50mg
询价
询价
100mg
询价
询价
250mg
询价
询价

产品描述

HDAC-IN-45(Compound 14)是一种具有抗癌活性且可与 Y303 残基形成氢键的小分子 HDAC 抑制剂,对 HDAC1、2 和 3 亚型具有显著抑制作用,IC50 分别为 0.108、0.585 和 0.563 μM。

生物实验数据

生物活性 HDAC-IN-45 (Compound 14) is a small-molecule HDAC inhibitor with anticancer activity that can also form a hydrogen bond with the Y303 residue, and it exhibits potent inhibitory activity against HDAC1, 2, and 3 isoforms with IC50 values of 0.108, 0.585, and 0.563 μM, respectively.
IC50 & Target HDAC8:6.81 μM, HDAC6:﹥10 μM, HDAC3:0.563 μM μM, HDAC2:0.585 μM, HDAC1:0.108 μM
体外研究
(In Vitro)

HDAC-IN-45 (Compound 14) suppresses the growth of triple-negative breast cancer cells MDA-MB-231 (IC50 = 1.48 μM), MDA-MB-468 (IC50= 0.65 μM), and liver cancer cells HepG2 (IC50= 2.44 μM).
HDAC-IN-45 has equally virulent in the HDAC-sensitive cell lines (YCC11) and -resistant gastric cell lines (YCC3/7) and overcome HDACi resistance. HDAC-IN-45 has a high toxicity (IC50= 0.33 μM) in three leukemic cell lines, K-562, KG-1 and THP-1.
HDAC-IN-45 (Compound 14) has substantial inhibitory effects towards HDAC1, 2 and 3 isoforms with IC50 values of 0.108, 0.585 and 0.563 μM respectively.
HDAC-IN-45 (Compound 14) can elevate acetylation level of histone H3 and expression of p21.
HDAC-IN-45 (Compound 14) exerts a dose-dependent upregulation of ac-H3K9 in MDA-MB-231 cells, triggers cell cycle arrest in G1 phase.
HDAC-IN-45 (Compound 14) exhibits a potent antitumor efficacy in xenograft mouse model.

Cell Proliferation Assay

Cell Line: Triple-negative breast cancer cells; liver cancer cells; YCC11 and YCC3/7
Concentration: a series of concentration
Incubation Time: 72 h
Result: Inhibited the cell growth viability of HepG2 and triple-negative breast cancer cells.

Cell Cytotoxicity Assay

Cell Line: Three leukemic cell lines (K-562, KG-1 and THP-1); YCC3/7 and YCC11 cell lines
Concentration: a series of concentration
Incubation Time: 72 h
Result: Showed a potent anti-cancer effect, exhibited high sensitivities and strong toxicities with IC50 values below micromolar in leukemic cell lines.

Western Blot Analysis

Cell Line: MDA-MB-231 cells
Concentration: 2 µM
Incubation Time: 24 h
Result: Elevated acetylation level of histone H3 and expression of p21.

Cell Cycle Analysis

Cell Line: MDA-MB-231cells
Concentration: 4 µM
Incubation Time: 24 h
Result: Arrested cell cycle in G1 and trigger apoptosis.
体内研究
(In Vivo)

HDAC-IN-45 (Compound 14) (25 mg/kg or 50mg/kg; i.p.; every day) exhibits a potent antitumor efficacy in human MDA-MB-231 breast cancer xenograft mouse model.

Animal Model: Human MDA-MB-231 breast cancer xenograft mouse model
Dosage: 25 mg/kg or 50mg/kg
Administration: 25 mg/kg or 50mg/kg; i.p.; every day.
Result: Exhibited a potent antitumor efficacy.

化学信息

分子量 502.93
分子式 C25H20ClFN8O
CAS No. 2421122-61-2

储存&溶解度

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

运输条件 Room temperature in continental US; may vary elsewhere.

计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
起始浓度(M)× 起始体积(L)= 最终浓度(M)× 最终体积(L)
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2
溶液体积 = 质量 ÷ 配液浓度
Volume (to add to vial) = Mass (in vial) ÷ Desired Reconstitution Concentration
÷
分子量计算器
Enter the chemical formula of the compound to calculate its molar mass and elemental composition
g/mol

体内实验配液计算器

动物实验计算换算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法:

比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL, 一共给药动物10只,您使用的配方为 10% DMSO + 40% PEG300 + 5% Tween 80 + 45% Saline / PBS / ddH2O, 那么您的工作液浓度为2 mg/mL。

母液配置方法:2 mg 药物溶于 100 μL DMSO ( 母液浓度为 20 mg/mL ), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。

体内配方的制备方法: 取 100 μL DMSO 母液, 添加 400 μL PEG300 混匀澄清, 再加 50 μL Tween 80, 混匀澄清, 再加 450 μL Saline / PBS / ddH2O 混匀澄清

以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。

方案所需的各类助溶剂如: DMSO, PEG300, PEG400, Tween 80, SBE-β-CD, 玉米油等, 均可在MolStrong网站点击购买。

第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系客服为您提供正确的澄清溶液配方)
+
+
+

计算结果:

工作液浓度: mg/ml;

DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,

体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL Saline/PBS/ddH2O,混匀澄清。

1. 首先保证母液是澄清的;
           2. 一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础